Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 209, Issue 2, Pages 439-447Publisher
WILEY
DOI: 10.1002/jcp.20740
Keywords
-
Categories
Funding
- NCRR NIH HHS [P20 RR015578, RR15578] Funding Source: Medline
- NICHD NIH HHS [R01 HD023924-14, HD23924, R01 HD023924, R01 HD023924-13A1, R01 HD023924-17, R01 HD023924-15, R01 HD023924-12, R01 HD023924-14S1, R01 HD023924-16] Funding Source: Medline
Ask authors/readers for more resources
The dystrophin-associated protein complex (DAPC), which links the cytoskeleton to the extracellular matrix, is essential for muscle cell survival, and is defective in a wide range of muscular dystrophies. The DAPC contains two transmembrane subcomplexes-the dystroglycans and the sarcoglycans. Although several extracellular binding partners have been identified for the dystroglycans, none have been described for the sarcoglycan subcomplex. Here we show that the small leucine-rich repeat (LRR) proteoglycan biglycan binds to alpha- and gamma-sarcoglycan as judged by ligand blot overlay and co-immunoprecipitation assays. Our studies with biglycan-decorin chimeras show that alpha-and gamma-sarcoglycan bind to distinct sites on the polypeptide core of biglycan. Both biglycan proteoglycan as well as biglycan polypeptide lacking glycosaminoglycan (GAG) side chains are components of the dystrophin glycoprotein complex isolated from adult skeletal muscle membranes. Finally, our immunohistochemical and biochemical studies with biglycan null mice show that the expression of alpha- and gamma-sarcoglycan is selectively reduced in muscle from young (P14-P21) animals, while levels in adult muscle (>= P35) are unchanged. We conclude that biglycan is a ligand for two members of the sarcoglycan complex and regulates their expression at discrete developmental ages.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available